Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Summary
This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.
Official title: A Multicenter, Randomized, Double-blind, Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Active Ankylosing Spondylitis
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
420
Start Date
2025-12-26
Completion Date
2027-08-30
Last Updated
2026-01-02
Healthy Volunteers
No
Conditions
Interventions
VC005 tablets
VC005 groups repeat administration for 48 weeks
VC005 Tablets Placebo
VC005 placebo groups repeat administration for 48 weeks
Locations (1)
Peking University People's Hospital
Beijing, Beijing Municipality, China